MC 2363 D-Cysteine, [1-14C]- Discontinued |
|
| HSCH2CH(NH2)COOH | |
| Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| 0.01N HCl solution, 100 μCi/ml | |
| > 50 mCi(1.85 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial | |
| M.W. 121.2 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 2675 D,L-Cysteine, [2-14C]- |
|
| HSCH2CH(NH2)COOH | |
| Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| 0.01N HCl solution, 100 μCi/ml | |
| > 50 mCi(1.85-2.22 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial | |
| M.W. 121.2 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MS 101 L-Cysteine, [35S]- Discontinued |
|
| HSCH2CH(NH2)COOH | |
| Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Aqueous solution, 10 mCi/ml | |
| ≥ 600 Ci(22.2 TBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial | |
| M.W. 121.2 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |